• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Computer Concepts for Medical Device Design

    IVD Manufacturers Are Being Put to the Test

    The New State of Medtech Outsourcing

    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Vascular Surgeon Imprisoned and Fined for Decade-Long Healthcare Fraud

    Remote Monitoring, Digital Health Help Advance Wound Care Treatment

    MLM Biologics Developing Wound Infection Prevention Device for Military

    NovaScan, PHC Corporation Working on Skin Cancer Detection Device

    Ur24Technology Granted Medicare Reimbursement for External Catheter System
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Computer Concepts for Medical Device Design

    IVD Manufacturers Are Being Put to the Test

    The New State of Medtech Outsourcing

    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Checking Up on Surgical Robotics

    Building a Network: How Synchron Is Developing a New Device—and a New Market

    Six Lessons Learned on Developing a Strong Company Culture

    As Hiring Slows, Companies Look Inward to Fulfill Talent Needs

    Artificial Intelligence: Medtech Opportunity or Health Danger?
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Halkey-Roberts Corporation

    JBC Technologies

    Providence Enterprise USA Inc.

    Arthur G. Russell Co. Inc., The

    Fusion Biotec Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    3 Key Elements to Consider When Managing a Medtech Sales Force

    Tech-Enabled Virtual Speech Therapy Improves Speech & Communication Skills

    Practical Strategies for Digitization and Integration in Medtech Manufacturing

    Sensors: The Heart of Minimally Invasive Equipment Technology

    Optimizing UX for the Internet of Medical Things
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Halkey-Roberts Corporation

    JBC Technologies

    Providence Enterprise USA Inc.

    Arthur G. Russell Co. Inc., The

    Fusion Biotec Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Features

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    Rising labor costs and supply chain disruptions are causing medical device manufacturers to reevaluate their overseas outsourcing strategies.

    The Big Shift: Nearshoring Trends in Medtech Manufacturing
    The Big Shift: Nearshoring Trends in Medtech Manufacturing
    Mark Crawford, Contributing Editor07.19.22
    For many decades, medical device manufacturers (MDMs) established operations in low-cost countries (primarily China) to take advantage of inexpensive labor overseas. However, escalating labor costs in China continue to erode this cost advantage; in response, over the last 10 to 15 years, nearshoring to Latin America, Mexico, and the Caribbean by U.S. companies has grown steadily. Now, with COVID-19 causing serious, long-duration supply chain disruptions, MDMs are even more motivated to shorten their supply chains and reduce operational costs through nearshoring.

    “Medical device companies are on the move,” said Lisa Anderson, president of LMA Consulting Group, a Claremont, Calif.-based consulting firm that specializes in manufacturing strategy and end-to-end supply chain transformation. “For example, Costa Rica continues to gain significant nearshoring opportunities. There is also strong growth in Mexico, which is still the number-one nearshoring option for MDMs because of its proximity to the U.S. and shorter lead times. Most MDMs realize that if they want to meet customer requirements today, they need better control over their production costs, and nearshoring is an attractive option for achieving this.”

    Now, more than two years into the COVID-19 pandemic, supply chain shortages are still rampant and delays continue to disrupt manufacturing processes—in fact, for some components and materials, lead times are longer now than they were during the peak of the pandemic. Further, when supply chains finally do settle down, how long will the calm last, and what will happen when the next international crisis erupts? Medical device companies are definitely rattled.

    Recent surveys show about two-thirds of North American manufacturers are interested in either nearshoring to a nearby country or bringing production back to the U.S. (reshoring).¹ Mexico is still the number-one destination for nearshoring, due to its modern manufacturing clusters, reliable communications infrastructure, skilled workers, established knowledge base, shared U.S. border, and long history of friendly relations between the two countries.

    Other top nearshoring destinations are the free trade zones in Latin America. In June 2022, the Inter-American Development Bank reported the potential gain for Latin American and Caribbean countries from nearshoring opportunities in the near future could be as much as from the export of goods and services, including medical devices, pharmaceuticals, and life sciences.

    In Costa Rica, the medical device and pharmaceutical industries continue to expand their presence. Nearshore production in Costa Rica has been so successful medical devices are now the country’s primary export. “In fact, after Mexico, Costa Rica is the most prolific exporter of medical devices in Latin America,” said Steve Colantuoni, director of marketing for San Salvador, El Salvador-based The Central American Group, which owns and operates the Green Park Free Zone in Costa Rica.

    Even with its nearshoring successes, the Dominican Republic continues to strengthen its position as a destination for MDMs. In September 2021, the Dominican Republic, Costa Rica, and Panama signed the Alliance for Development in Democracy, which allows for greater utilization of the proximity of markets, promotes greater flow of trade and investment, and reduces vulnerabilities in supply chains. “The National Free Zones Council, as the institution that regulates and promotes the free zone sector in the Dominican Republic, together with the Ministry of Industry, Commerce, and MSMEs and the Dominican Association of Free Zones, have worked to design a strategy to strengthen and improve ease of doing business, promotion of investment, education, infrastructure, and industrial linkages,” said Yarisol Lopez, deputy executive director for the National Free Zones Council of the Dominican Republic, located in Santo Domingo.

    Advantages of Nearshoring/Reshoring

    Significant benefits await MDMs that nearshore. When the pandemic began, the big driver for nearshoring/reshoring was a more stable and efficient logistical system. Some overseas governments forced their MDMs to prioritize domestic production, as well as closed ports, which extended lead times by months and even years. Huge supply chain fluctuations created such business continuity risks for some companies that they decided to leave these low-cost countries. “Companies that want to stay competitive and be sure they can support customer needs should seriously consider nearshoring,” said Anderson.

    In addition to reducing risk, companies that nearshore can enjoy the following benefits:
    • Improved product quality and reliability (better quality systems, communication, decision making)
    • Easier and more frequent travel, allowing manufacturing teams to communicate more effectively
    • Higher-quality infrastructure—the business infrastructure in Latin America is more reliable than many offshore locations, such as Europe and India
    • Less working capital required to support customer requirements
    • Reduced freight costs with a shorter supply chain
    • Better flexibility for handling change orders and scheduling adjustments
    • Reduced turnaround for product development and rollout
    • Reduced shipping and transportation costs (and no import tariffs if reshored to the U.S.)
    • Lower energy costs—reduced consumption of energy for operations and shipping has positive environmental impacts
    • Greater supply chain control results in faster delivery and reduced warehouse space
    • Being geographically closer to the end customer shortens delivery times, simplifies scheduling, and decreases transportation costs
    A skilled and plentiful workforce is high on the list of any MDM. Nearshore manufacturing locations in Latin America are known for their highly skilled workers because of the national emphasis on technical degrees. For example, engineering programs in Mexico educate thousands of engineers and technicians every year, providing MDMs with plenty of efficient and innovative talent. Costa Rica also has a highly-educated workforce where “98% of the population is literate, including a wealth of engineering talent that is bilingual,” added Colantuoni.

    Challenges to Nearshoring

    Making the right nearshoring decision can be complicated and relies on a number of factors that must be accurately evaluated. An MDM needs to determine if it will be manufacturing a product, sourcing a domestic supplier, or both. If the company manufactures, it will need to source raw materials, components, or ingredients. It is also possible that materials will be required to be sent to outside suppliers, which will need sourcing and purchasing expertise. “From a manufacturing standpoint, the complexity of the operation will depend on if the company manufactures elsewhere in the world, where it can pull people with the expertise to set up new manufacturing,” said Anderson. “If not, the company will need to hire talent.”

    The difficulty of establishing a new supply chain for nearshoring/reshoring depends on an MDM’s current supply chain network, partners, and capabilities. In general, it is easier to find a compatible, qualified partner in the U.S.; “however,” noted Anderson, “if there is significant volume to reshore, it is harder to find a supplier that can take on additional volume. This might then require developing a strategic partnership and jointly investing in expansion.”

    According to Harry Moser, president and founder of the Reshoring Initiative, a Sarasota, Fla.-based organization that helps U.S. manufacturers navigate the decision making process for reshoring their operations from low-cost countries, companies source products and locate their factories abroad at least 70% of the time based on FOB (free on board) price/manufacturing cost (“price”) comparisons of the offshore versus the domestic source. FOB costs “exclude transportation of goods, loading, marine freight transport, insurance, and unloading and transporting the goods from the arrival port to the final destination plus 20 other costs and risks,” said Moser.

    When companies make sourcing decisions based solely on price, and not on a more carefully calculated total cost of ownership (TCO), it can often result in a 20% to 30% miscalculation of actual offshoring costs, noted Moser. The Reshoring Initiative provides a free online tool called the Total Cost of Ownership (TCO) Estimator that helps companies account for all relevant factors—overhead, balance sheet, risks, corporate strategy, and other external and internal business considerations—to determine the true total cost of ownership.2 “This way, companies can better evaluate sourcing, identify alternatives, and even make a case when selling against offshore competitors,” Moser said.

    Endorsed by the U.S. Department of Commerce, the TCO Estimator is designed for businesses of all sizes and allows users to determine which sources best meet the company’s profitability and strategic objectives. The analysis includes:
    • Calculations of 30 cost and risk factors for each source
    • An accumulation of all costs into cost categories
    • The TCO for each source
    • Line charts showing each source’s current price and TCO and a five-year TCO forecast
    • Line charts showing your cumulative cost by category for each source
    Another resource offered by the Reshoring Initiative is the Import Substitution Program (ISP), which identifies and qualifies major importers of the products a U.S. company produces.³ Instead of competing with other local companies for work, ISP can identify new opportunities with no local competition.

    “We also publish comprehensive data on thousands of reshoring cases annually to show companies that their peers are successfully reshoring and that they should re-evaluate their sourcing and siting decisions using TCO and seek customers using ISP,” said Moser.

    Although this all sounds straightforward, the direct costs expectations may require a mind shift.

    “Labor costs overseas and nearshore can be equivalent, but in order to reshore manufacturing, new technologies may need to be explored to mitigate U.S. labor costs,” said Attly Aycock, CEO for Remington Medical, an Alpharetta, Ga.-based contract manufacturer of medical devices with a 30,000-square-foot facility in Santo Domingo, Dominican Republic. “Therefore, a mind shift may be required to look at the total cost of generating a product. The reduced logistics, decreased lead times, and other cost reduction factors must play into the equation.”

    Another nearshoring challenge is how to strategically exit from an overseas manufacturer. This is usually done gradually—as the new location ramps up, the previous location gets less work. This can take some time and is a balancing act for all parties involved. MDMs that nearshore/reshore must also be sure all the appropriate rules and regulations are met. “At Remington, we have a dedicated staff to aid in any regulatory hurdles that may be in the way,” said Aycock.

    Technology Advantages

    The bottom line for the viability of nearshoring/reshoring is profitability and competitiveness. In order to successfully manufacture medical devices in nearshore/reshore locations, MDMs must find ways to cut costs and still maintain decent margins. COVID-19 forced many U.S. manufacturers to try Industry 4.0/Internet of Things (IoT) technologies, which greatly improved efficiency and reduced costs. With this positive experience, MDMs know these technologies, when utilized in nearshore/reshore operations, can go a long way toward making them cost-competitive with low-cost countries.

    “The smartest companies will get ahead of the technology curve immediately,” said Anderson. “They are already upgrading their enterprise resource planning systems and planning software and processes, as well as implementing automation, robotics, and other technologies. As these companies automate, they need fewer people to run the machines, which is essential for reducing labor cost and making adjustments on the fly.”

    For nearshoring/reshoring locations, all modern technologies must be evaluated to see if they can make these locations competitive with low-cost countries. This also includes analyzing current production methods. In some cases, a complete design for manufacturability study may be required. “This could lead to small design changes that greatly reduce the labor input required to make a device,” said Aycock. “When launching a device from a low-cost country, ease of assembly is sometimes an afterthought because the idea is that you can always throw more cheap labor at the problem. But if you can make the small changes that reduce the inputs, you can often find a way to make that product locally, while still protecting margins.”

    IoT and 4.0 are essential for creating very robust and repeatable processes and nearshore countries are active in making these technologies available to MDMs and other companies that want to relocate their operations to their free zones. “It is critical to provide access to the technologies needed for creating very consistent processes,” said Omar Jimenez, general coordinator of the medical device manufacturers cluster of the Dominican Republic. “These include sensors that alert maintenance technicians of a potential failure in critical equipment, vision systems that can detect defects in the micron range, artificial-intelligence-enabled cameras that improve assembly procedures, and automated equipment that replaces labor on key processes where consistency is critical.”

    Nearshoring Through a Contract Manufacturer

    Nearshore countries have proven to be innovative industrial hubs that attract a large number of U.S. manufacturing companies. For example, a variety of well-known U.S. manufacturers operate in the Dominican Republic, including Jabil, GE Energy, Johnson & Johnson, and Cardinal Health. In 2021, Costa Rica exported medical devices worth a total of $5 billion4 and 2022 is off to a good start (20% year-over-year growth compared to 2021). In fact, during the COVID-19 pandemic, the Costa Rican medical device sector successfully maintained operations, boosting production in 2020 by 8%, which reflects a remarkable level of expertise and resiliency that continues to impress MDMs. For example, in June 2021, Lakewood, Colo.-based Terumo Blood and Cell Technologies announced plans to open a medical device manufacturing facility in Costa Rica, creating 700 new jobs.

    “We chose Costa Rica for our new manufacturing plant because it is a proven hub for the production of medical devices,” said Chris Williams, senior vice president of global manufacturing for Terumo Blood and Cell Technologies. “Our customers and patients rely on us to deliver high-quality products and outstanding services. Costa Rica has the resources, talent, and solid supply chain infrastructure that we need to fulfill our commitments.”5

    One way to enjoy the benefits of nearshoring without the headaches of starting up your own operation is to work through qualified contract manufacturers in a nearshore location. These companies are deeply experienced and have well-established local and regional supply chains. Vibrant Mexican and Latin American medical device clusters also attract an abundance of potential supply chain partners that are eager to support these MDMs. For example, the supply chain ecosystem in Costa Rica has expanded greatly since the medical device cluster there began in 1987. “Now, with a cluster of about 70 medical device manufacturers, the supplier base has expanded,” said Colantuoni. “This has made it easier to establish effective supply chains close to manufacturing operations.”

    Remington Medical manufactures custom medical devices at its nearshore facility in the Dominican Republic. With its well-developed supply chain, time zone constraints, freight time delays, and IP issues are all minimized.

    “We have shifted hundreds of Remington Medical brand name products and products for our contract manufacturing customers to the Dominican Republic location,” said Aycock. “This has allowed Remington to grow in both locations and today, we produce nearly the same number of devices in the U.S. as we do in the Dominican Republic.”

    Not every project, however, will benefit from nearshoring.

    Before moving an MDM’s project to the Dominican Republic for production, Remington Medical examines all the parameters involved, especially total cost.

    “When the materials make up most of the costs, it may be viable to produce it in the U.S.,” said Aycock. “When labor contributes more heavily to the cost, we must evaluate the complexity of the device and determine if the logistics lend itself to production in the Dominican. Sometimes it does and sometimes it doesn’t, but ultimately, it is a strategic business decision that we make together with our contract manufacturing customers.”

    Selecting the Right Partner

    Ultimately, when nearshoring from overseas, it is paramount to have a thorough, well-thought-out project plan in place, which includes a solid analysis of the regulatory submittal process. “It will take time,” said Aycock, “but it is time that you will get back once the transition is complete. If you are going to nearshore/reshore your medical device, be certain that you have a contract manufacturing partner that is deeply experienced in making medical devices in that location, with an established quality system and history of tackling medical device projects.”

    “MDMs must very careful to select a reputable local partner to help them in the process of starting their operations,” agreed Colantuoni. “It is also important to find a skilled local to run the nearshored operation. Having the right person in a leadership position will help the investor to successfully navigate the culture.”

    Nearshoring and reshoring represent a new reality that is taking place in not only the U.S., but in Europe and other regions of the world as well.

    These manufacturers want greater control of their operations, noted Anderson.

    “Companies no longer want to be at the mercy of political, infrastructure, and other challenges facing outside governments, not to mention the logistics nightmares of late,” she said. “A recent survey indicated that 80% of executives expect to be reshoring in 2022, compared to 54% the previous year. It just makes sense to be closer to your operations and, most important, be closer to your customer.”

    Having faced widespread supply chain disruptions over the past two years, manufacturers across the U.S. are increasingly sourcing components closer to home to bolster resilience and ensure product reliability.

    “All along, our argument has been the total cost of ownership,” said Moser. “Do not just look at the factory price—look at all the relevant costs and risks. That was our argument 10 years ago, and it is still our argument today. The thing is, recent disruptions have made the argument a lot more credible now.” 

    References
    1. bit.ly/mpo220761
    2. bit.ly/mpo220762
    3. bit.ly/mpo220763
    4. bit.ly/mpo220764
    5. bit.ly/mpo220765


    Mark Crawford is a full-time freelance business and marketing/communications writer based in Madison, Wis. His clients range from startups to global manufacturing leaders. He also writes a variety of feature articles for regional and national publications and is the author of five books.
    Related Searches
    • Contract Manufacturing
    Related Knowledge Center
    • Contract Manufacturing
      Loading, Please Wait..

      Trending
      • Philips Names New Supervisory Board Chairman
      • A New Approach To Post-Market Surveillance
      • Healthcare Changes Prompt Medtronic To Merge Sales Force Medtronic, Inc. Is Combining Its U.S. Ca
      • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
      • Vascular Surgeon Imprisoned And Fined For Decade-Long Healthcare Fraud
      Breaking News
      • Vascular Surgeon Imprisoned and Fined for Decade-Long Healthcare Fraud
      • Remote Monitoring, Digital Health Help Advance Wound Care Treatment
      • MLM Biologics Developing Wound Infection Prevention Device for Military
      • NovaScan, PHC Corporation Working on Skin Cancer Detection Device
      • Ur24Technology Granted Medicare Reimbursement for External Catheter System
      View Breaking News >
      CURRENT ISSUE

      May 2023

      • Computer Concepts for Medical Device Design
      • IVD Manufacturers Are Being Put to the Test
      • The New State of Medtech Outsourcing
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Premium Label & Packaging Solutions Receives Safe Quality Food (SQF) Certification
      Inulinase Enzymes May Benefit Gut Symptoms of FODMAP Digestion
      Verdure Sciences’ Boswellia Ingredient Receives USP Verification
      Coatings World

      Latest Breaking News From Coatings World

      BASF Celebrates 10 Years of its Northeast Research Alliance in the U.S.
      BCF Elects Sharon Harte Its First Female President
      OQ Chemicals Launches Cost-Cutting Program and Organizational Realignment in Germany
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Vascular Surgeon Imprisoned and Fined for Decade-Long Healthcare Fraud
      Remote Monitoring, Digital Health Help Advance Wound Care Treatment
      MLM Biologics Developing Wound Infection Prevention Device for Military
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Catalent Adds New Cryogenic Capabilities at Japanese Facility
      Lifecore Biomedical Enters into $150M New Financing Deal
      WuXi Biologics Receives 2023 ISPE Facility of the Year Award
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      How Robots & Artificial Intelligence are Transforming Unilever's Material Innovation Factory
      Top 10 Most Popular Hair Care Brands in the U.S.—Ranked by Searches
      Aloette Cosmetics Launches Daily Mineral Shield Sunscreen
      Happi

      Latest Breaking News From Happi

      Kérastase Donates $25,000 to The Trevor Project
      Aveda Launches Hypernature Artist Collection
      Amika Leads as the Most Popular Hair Care Brand in the US: Curl Centric
      Ink World

      Latest Breaking News From Ink World

      BCF Elects Sharon Harte First Female President in Its History
      Weekly Recap: INX Digital, Mexar and hubergroup Top This Week’s Stories
      Richnerstutz AG Acquires an EFI VUTEk Q5r Superwide Roll-to-Roll Printer
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Mactac acquires Label Supply, Beontag grows and more
      Sun Chemical releases Spring 2023 Regulatory Newsletter
      Tageos unveils new RAIN RFID inlays
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Weekly Recap: Corman, Tosama Develop Biodegradable Plastic Tampon Applicator, Trevira Changes Name
      Suominen Appoints SVP, Transformation Management Office
      Minnesota Signs PFAS Ban in Consumer Products
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      AlloSource Launches AlloMend Duo Acellular Dermal Matrix
      TendoNova Inks Partnership With AcCELLerated Biologics
      Stryker Achieves First Surgeries Using Q Guidance System with Cranial Guidance Software
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Partner Workshops Start Solliance 2.0
      Weekly Recap: Smart Skis, Universal Display Top This Week’s Stories
      Wiliot Appoints Antony Yousefian as VP of Climate & Circularity

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login